Nanotechnology-Abetted Astaxanthin Formulations in Multimodel Therapeutic and Biomedical Applications.
Zohreh JafariAshkan BighamSahar SadeghiSayed Mehdi DehdashtiNavid RabieeAlireza AbedivashMojtaba BagherzadehBehzad NasseriHassan Karimi-MalehEsmaeel SharifiRajender S VarmaGiuseppe PeralePublished in: Journal of medicinal chemistry (2021)
Astaxanthin (AXT) is one of the most important fat-soluble carotenoids that have abundant and diverse therapeutic applications namely in liver disease, cardiovascular disease, cancer treatment, protection of the nervous system, protection of the skin and eyes against UV radiation, and boosting the immune system. However, due to its intrinsic reactivity, it is chemically unstable, and therefore, the design and production processes for this compound need to be precisely formulated. Nanoencapsulation is widely applied to protect AXT against degradation during digestion and storage, thus improving its physicochemical properties and therapeutic effects. Nanocarriers are delivery systems with many advantages─ease of surface modification, biocompatibility, and targeted drug delivery and release. This review discusses the technological advancement in nanocarriers for the delivery of AXT through the brain, eyes, and skin, with emphasis on the benefits, limitations, and efficiency in practice.
Keyphrases
- drug delivery
- cancer therapy
- cardiovascular disease
- optical coherence tomography
- drug release
- soft tissue
- primary care
- healthcare
- adipose tissue
- type diabetes
- white matter
- multiple sclerosis
- coronary artery disease
- metabolic syndrome
- brain injury
- cardiovascular risk factors
- blood brain barrier
- cataract surgery
- functional connectivity
- cerebral ischemia